CE Mark for MicroMatrix, Cytal Wound Matrix and Cytal Burn Matrix devices for burn and wound management - ACell Inc.

ACell, Inc., a leading regenerative medicine company, announced that it has received CE mark approval for its MicroMatrix , Cytal Wound Matrix, and Cytal Burn Matrix devices. This regulatory approval allows ACell to distribute these products throughout the 27 countries of the European Union. MicroMatrix, Cytal Wound Matrix, and Cytal Burn Matrix have received CE Mark approval according to the Medical Device Directive and are intended for the management of wounds including partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-mohs surgery, post-laser surgery podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears), and draining wounds. These devices are intended for one-time use.